235 related articles for article (PubMed ID: 10841521)
1. Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction.
Lode HN; Xiang R; Pertl U; Förster E; Schoenberger SP; Gillies SD; Reisfeld RA
J Clin Invest; 2000 Jun; 105(11):1623-30. PubMed ID: 10841521
[TBL] [Abstract][Full Text] [Related]
2. Mucosally induced systemic T cell unresponsiveness to ovalbumin requires CD40 ligand-CD40 interactions.
Kweon MN; Fujihashi K; Wakatsuki Y; Koga T; Yamamoto M; McGhee JR; Kiyono H
J Immunol; 1999 Feb; 162(4):1904-9. PubMed ID: 9973457
[TBL] [Abstract][Full Text] [Related]
3. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
[TBL] [Abstract][Full Text] [Related]
4. CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells.
Ribas A; Butterfield LH; Amarnani SN; Dissette VB; Kim D; Meng WS; Miranda GA; Wang HJ; McBride WH; Glaspy JA; Economou JS
Cancer Res; 2001 Dec; 61(24):8787-93. PubMed ID: 11751400
[TBL] [Abstract][Full Text] [Related]
5. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
Gao D; Li J; Orosz CG; Bumgardner GL
Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
[TBL] [Abstract][Full Text] [Related]
6. CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses.
Whitmire JK; Flavell RA; Grewal IS; Larsen CP; Pearson TC; Ahmed R
J Immunol; 1999 Sep; 163(6):3194-201. PubMed ID: 10477587
[TBL] [Abstract][Full Text] [Related]
7. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.
Oxenius A; Campbell KA; Maliszewski CR; Kishimoto T; Kikutani H; Hengartner H; Zinkernagel RM; Bachmann MF
J Exp Med; 1996 May; 183(5):2209-18. PubMed ID: 8642330
[TBL] [Abstract][Full Text] [Related]
8. B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interactions.
Maruo S; Oh-hora M; Ahn HJ; Ono S; Wysocka M; Kaneko Y; Yagita H; Okumura K; Kikutani H; Kishimoto T; Kobayashi M; Hamaoka T; Trinchieri G; Fujiwara H
J Immunol; 1997 Jan; 158(1):120-6. PubMed ID: 8977182
[TBL] [Abstract][Full Text] [Related]
9. Role of the endogenous production of interleukin 12 in immunotherapy.
Harada M; Tamada K; Abe K; Yasumoto K; Kimura G; Nomoto K
Cancer Res; 1998 Jul; 58(14):3073-7. PubMed ID: 9679973
[TBL] [Abstract][Full Text] [Related]
10. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
[TBL] [Abstract][Full Text] [Related]
11. CD28, TNF receptor, and IL-12 are critical for CD4-independent cross-priming of therapeutic antitumor CD8+ T cells.
Hu HM; Winter H; Ma J; Croft M; Urba WJ; Fox BA
J Immunol; 2002 Nov; 169(9):4897-904. PubMed ID: 12391201
[TBL] [Abstract][Full Text] [Related]
12. Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4.
Macaulay AE; DeKruyff RH; Goodnow CC; Umetsu DT
J Immunol; 1997 May; 158(9):4171-9. PubMed ID: 9126977
[TBL] [Abstract][Full Text] [Related]
13. Interaction of Macrophage Antigen 1 and CD40 Ligand Leads to IL-12 Production and Resistance in CD40-Deficient Mice Infected with Leishmania major.
Okwor I; Jia P; Uzonna JE
J Immunol; 2015 Oct; 195(7):3218-26. PubMed ID: 26304989
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells.
Kikuchi T; Crystal RG
Hum Gene Ther; 1999 May; 10(8):1375-87. PubMed ID: 10365667
[TBL] [Abstract][Full Text] [Related]
15. In vivo polysaccharide-specific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7-ligand interactions.
Wu ZQ; Vos Q; Shen Y; Lees A; Wilson SR; Briles DE; Gause WC; Mond JJ; Snapper CM
J Immunol; 1999 Jul; 163(2):659-67. PubMed ID: 10395655
[TBL] [Abstract][Full Text] [Related]
16. CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation.
Hermann P; Van-Kooten C; Gaillard C; Banchereau J; Blanchard D
Eur J Immunol; 1995 Oct; 25(10):2972-7. PubMed ID: 7589100
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells.
Johnson-Léger C; Christenson JR; Holman M; Klaus GG
J Immunol; 1998 Nov; 161(9):4618-26. PubMed ID: 9794390
[TBL] [Abstract][Full Text] [Related]
18. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages.
Kennedy MK; Picha KS; Fanslow WC; Grabstein KH; Alderson MR; Clifford KN; Chin WA; Mohler KM
Eur J Immunol; 1996 Feb; 26(2):370-8. PubMed ID: 8617306
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of CD40 ligand: elicitation of local and systemic antitumor responses by IL-12 and B7.
Nakajima A; Kodama T; Morimoto S; Azuma M; Takeda K; Oshima H; Yoshino S; Yagita H; Okumura K
J Immunol; 1998 Aug; 161(4):1901-7. PubMed ID: 9712059
[TBL] [Abstract][Full Text] [Related]
20. Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells.
Kikuchi T; Miyazawa N; Moore MA; Crystal RG
Cancer Res; 2000 Nov; 60(22):6391-5. PubMed ID: 11103803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]